Sign inGet started

IDRA

IDERA PHARMACEUTICALS, INC.CIK 861838 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
49

AI insights for IDRA PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for IDRA
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
DOUGHERTY MICHAEL RDirector19$101.2K$02023-01-11
Lim Bryant DavidSVP and General Counsel20$12.2K$29.0K2023-01-06
Kirby John J.VP of Finance19$6.2K$22.6K2023-01-06
JORDAN ANDREW RChief Strategy Officer4$0$02023-01-06
NQ POF V GP, Ltd.Director4$0$02022-09-28
Taylor John ClaytonChief Executive Officer2$0$02022-09-28
Kraus Carl NChief Medical Officer3$0$02022-09-28
Salain DanielChief Operating Officer2$0$02022-09-28
WOOTEN RONALD JDirector4$0$02022-09-28
ZEIN YOUSSEF ELDirector, 10% Owner75$10.8K$368.0K2022-09-22
SOLAND DANIEL BChief Operating Officer7$98.5K$02022-07-06
MILANO VINCENTPresident and CEO26$977.9K$195.5K2022-07-06
Goldberg Mark AlanDirector17$31.9K$02022-06-23
Csimma CristinaDirector5$0$02022-06-23
GOWEN MAXINEDirector11$10.5K$02022-06-23
SCHAFER CAROLDirector14$16.6K$02022-06-23
GERAGHTY JAMES ADirector28$843.5K$02022-06-23
Pillar Invest CorpDirector, 10% Owner38$0$4.91M2021-04-01
Umari Abude10% Owner13$127.3K$3.06M2021-03-26
Tarka Elizabeth AnnChief Medical Officer7$0$14.1K2021-03-25
PIEN HOWARD HDirector11$0$02020-10-01
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy13$0$5.7K2020-07-21
Pillar Partners Foundation, L.P.10% Owner6$5.91M$02020-07-13
Pillar Pharmaceuticals III, L.P.10% Owner4$0$559.0K2020-01-29
YINGLING JONATHAN MICHAELSVP, Early Development11$0$6.2K2020-01-10
Pillar Pharmaceuticals 6, L.P.10% Owner3$0$296.5K2019-11-08
Horobin JoannaSVP and Chief Medical Officer9$1.0K$02019-07-09
BAKER JULIANDirector15$0$02019-07-01
BAKER FELIXDirector, 10% Owner24$0$02019-06-06
667, L.P.Director, 10% Owner20$6.50M$02019-04-01
14159, L.P.Director, 10% Owner11$0$02019-01-02
BAKER BROS. ADVISORS LPDirector, 10% Owner6$0$02018-10-01
Arcudi III Louis JChief Financial Officer9$0$02018-08-13
Pillar Pharmaceuticals II, L.P.Director, 10% Owner30$0$9.65M2018-08-09
Baker Brothers Life Sciences LPDirector, 10% Owner14$32.00M$02018-07-02
Baker Bros. Advisors (GP) LLCDirector, 10% Owner4$0$02018-06-20
REARDON WILLIAM SDirector12$24.7K$02018-06-20
Casey Mark JSenior VP and General Counsel6$49.6K$02018-01-03
AGRAWAL SUDHIRPresident of Research12$0$02017-01-03
Slater Eve ElizabethDirector5$0$02015-06-08
Wolf John Peter IIIGeneral Counsel1$0$02014-12-10
BRENNER LOUIS MDChief Medical Officer2$0$02014-12-10
MacCoss MalcolmDirector6$0$02014-07-01
KARR ROBERT WDirector5$10.1K$02014-06-09
Sullivan Timothy MVP Development Programs9$0$438.4K2014-05-27
Abdul-Wahab UmariDirector26$0$02014-05-23
Arbeit Robert D.VP Clinical Development4$0$02013-12-10
HARTLEY C KEITHDirector5$45.0K$02013-08-16
Senator Investment Group LP10% Owner12$0$997.0K2012-04-23

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
DOUGHERTY MICHAEL RDirector A Award2023-01-112023-01-1233,523$0.44 $14.8K375,155SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER F Tax w/h2023-01-062023-01-10119,957$0.71 $85.2K316,893SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER A Award2023-01-062023-01-10399,218— $0436,850SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL F Tax w/h2023-01-062023-01-10119,957$0.71 $85.2K309,695SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL A Award2023-01-062023-01-10399,218— $0429,652SEC↗
JORDAN ANDREW RCHIEF STRATEGY OFFICER A Award2023-01-062023-01-10261,718— $0913,082SEC↗
JORDAN ANDREW RCHIEF STRATEGY OFFICER F Tax w/h2023-01-062023-01-1073,940$0.71 $52.5K839,142SEC↗
DOUGHERTY MICHAEL RDirector A Award2022-10-032022-10-0558,516$0.37 $21.7K341,632SEC↗
NQ POF V GP, Ltd.Director J Other deriv2022-09-282022-10-031,343,547— $01,343,547SEC↗
NQ POF V GP, Ltd.Director J Other deriv2022-09-282022-10-0314,115— $014,115SEC↗
NQ POF V GP, Ltd.Director J Other deriv2022-09-282022-10-0314,115— $014,115SEC↗
NQ POF V GP, Ltd.Director J Other2022-09-282022-10-035— $05SEC↗
JORDAN ANDREW RChief Strategy Officer A Award deriv2022-09-282022-09-306,843— $06,843SEC↗
Kraus Carl NChief Medical Officer A Award deriv2022-09-282022-09-306,843— $06,843SEC↗
Kraus Carl NChief Medical Officer A Award deriv2022-09-282022-09-306,843— $06,843SEC↗
Kraus Carl NChief Medical Officer A Award deriv2022-09-282022-09-30651,364— $0651,364SEC↗
Salain DanielChief Operating Officer A Award deriv2022-09-282022-09-3022,810— $022,810SEC↗
Taylor John ClaytonChief Executive Officer A Award deriv2022-09-282022-09-3022,810— $022,810SEC↗
WOOTEN RONALD JDirector J Other deriv2022-09-282022-09-3014,115— $014,115SEC↗
WOOTEN RONALD JDirector J Other deriv2022-09-282022-09-301,343,547— $01,343,547SEC↗
WOOTEN RONALD JDirector J Other deriv2022-09-282022-09-3014,115— $014,115SEC↗
JORDAN ANDREW RChief Strategy Officer A Award2022-09-282022-09-30651,364— $0651,364SEC↗
Salain DanielChief Operating Officer A Award2022-09-282022-09-302,171,214— $02,171,214SEC↗
Taylor John ClaytonChief Executive Officer A Award2022-09-282022-09-302,171,214— $02,171,214SEC↗
WOOTEN RONALD JDirector J Other2022-09-282022-09-305— $05SEC↗
ZEIN YOUSSEF EL10% Owner X Exercise deriv2022-09-222022-09-261,533,159— $01,533,159SEC↗
ZEIN YOUSSEF EL10% Owner X Exercise2022-09-222022-09-261,533,159$0.01 $15.3K7,266,954SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER A Award deriv2022-07-062022-07-0766,500— $066,500SEC↗
MILANO VINCENTPRESIDENT AND CEO A Award deriv2022-07-062022-07-07124,000— $0124,000SEC↗
SOLAND DANIEL BCHIEF OPERATING OFFICER A Award deriv2022-07-062022-07-0766,500— $066,500SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL A Award deriv2022-07-062022-07-0766,500— $066,500SEC↗
DOUGHERTY MICHAEL RDirector A Award2022-07-012022-07-0650,086$0.44 $22.0K283,116SEC↗
SCHAFER CAROLDirector A Award deriv2022-06-232022-06-2726,000— $026,000SEC↗
Csimma CristinaDirector A Award deriv2022-06-232022-06-2726,000— $026,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2022-06-232022-06-2726,000— $026,000SEC↗
Goldberg Mark AlanDirector A Award deriv2022-06-232022-06-2726,000— $026,000SEC↗
DOUGHERTY MICHAEL RDirector A Award deriv2022-06-232022-06-2726,000— $026,000SEC↗
GOWEN MAXINEDirector A Award deriv2022-06-232022-06-2726,000— $026,000SEC↗
MILANO VINCENTPRESIDENT AND CEO A Award deriv2022-04-012022-04-0499,000— $099,000SEC↗
SOLAND DANIEL BCHIEF OPERATING OFFICER A Award deriv2022-04-012022-04-0441,500— $041,500SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL A Award deriv2022-04-012022-04-0441,500— $041,500SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER A Award deriv2022-04-012022-04-0441,500— $041,500SEC↗
DOUGHERTY MICHAEL RDirector A Award2022-04-012022-04-0541,155$0.54 $22.2K233,030SEC↗
MILANO VINCENTPRESIDENT AND CEO A Award deriv2022-01-242022-01-2625,000— $025,000SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER A Award deriv2022-01-242022-01-2625,000— $025,000SEC↗
SOLAND DANIEL BCHIEF OPERATING OFFICER A Award deriv2022-01-242022-01-2625,000— $025,000SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL A Award deriv2022-01-242022-01-2625,000— $025,000SEC↗
DOUGHERTY MICHAEL RDirector A Award2022-01-032022-01-0537,062$0.59 $21.9K191,875SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER P Buy2021-12-172021-12-2110,000$0.62 $6.2K37,632SEC↗
DOUGHERTY MICHAEL RDirector A Award2021-10-042021-10-0421,229$1.03 $21.9K154,813SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER A Award deriv2021-07-082021-07-1266,500— $066,500SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL A Award deriv2021-07-082021-07-1266,500— $066,500SEC↗
SOLAND DANIEL BCHIEF OPERATING OFFICER A Award deriv2021-07-082021-07-1266,500— $066,500SEC↗
MILANO VINCENTPRESIDENT AND CEO A Award deriv2021-07-082021-07-12124,000— $0124,000SEC↗
SOLAND DANIEL BCHIEF OPERATING OFFICER P Buy2021-06-182021-06-2150,000$1.19 $59.5K78,843SEC↗
SCHAFER CAROLDirector A Award deriv2021-06-082021-06-1026,000— $026,000SEC↗
Csimma CristinaDirector A Award deriv2021-06-082021-06-1026,000— $026,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2021-06-082021-06-1026,000— $026,000SEC↗
Goldberg Mark AlanDirector A Award deriv2021-06-082021-06-1026,000— $026,000SEC↗
DOUGHERTY MICHAEL RDirector A Award deriv2021-06-082021-06-1026,000— $026,000SEC↗
GOWEN MAXINEDirector A Award deriv2021-06-082021-06-1026,000— $026,000SEC↗
DOUGHERTY MICHAEL RDirector P Buy2021-06-012021-06-0385,000$1.19 $101.2K133,584SEC↗
Pillar Invest Corp10% Owner X Exercise deriv2021-04-012021-04-291,612,196$0.01 $16.1K1,612,196SEC↗
Pillar Invest Corp10% Owner X Exercise deriv2021-04-012021-04-29883,613$0.01 $8.8K883,613SEC↗
DOUGHERTY MICHAEL RDirector A Award2021-04-012021-04-0510,939$1.32 $14.4K48,584SEC↗
GERAGHTY JAMES ADirector A Award2021-04-012021-04-0514,773$1.32 $19.5K119,543SEC↗
Goldberg Mark AlanDirector A Award2021-04-012021-04-0510,511$1.32 $13.9K48,610SEC↗
SCHAFER CAROLDirector A Award2021-04-012021-04-0511,177$1.32 $14.8K59,665SEC↗
Pillar Invest Corp10% Owner X Exercise2021-04-012021-04-29883,613$0.01 $8.8K2,304,180SEC↗
Pillar Invest Corp10% Owner X Exercise2021-04-012021-04-291,612,196$0.01 $16.1K5,733,795SEC↗
Umari Abude10% Owner X Exercise deriv2021-03-262021-03-31884,175$0.01 $8.8K884,175SEC↗
Umari Abude10% Owner X Exercise deriv2021-03-262021-03-311,611,634$0.01 $16.1K1,611,634SEC↗
Umari Abude10% Owner X Exercise2021-03-262021-03-311,611,634$0.01 $16.1K5,733,233SEC↗
Umari Abude10% Owner X Exercise2021-03-262021-03-31884,175$0.01 $8.8K2,492,342SEC↗
Kirby John J.CHIEF FINANCIAL OFFICER S Sale2021-03-252021-03-296,250$1.42 $8.9K27,632SEC↗
Lim Bryant DavidSVP AND GENERAL COUNSEL S Sale2021-03-252021-03-297,630$1.36 $10.4K30,434SEC↗
Tarka Elizabeth AnnCHIEF MEDICAL OFFICER S Sale2021-03-252021-03-295,018$1.35 $6.8K13,237SEC↗
Umari Abude10% Owner S Sale2021-03-182021-03-311,376,039$1.80 $2.48M4,121,599SEC↗
Umari Abude10% Owner S Sale2021-03-182021-03-31323,726$1.80 $582.7K1,608,167SEC↗
SOLAND DANIEL BCHIEF OPERATING OFFICER P Buy2021-03-052021-03-0510,000$3.90 $39.0K28,843SEC↗
Umari Abude10% Owner X Exercise deriv2021-01-202021-03-31643,525$0.01 $6.4K643,525SEC↗
Umari Abude10% Owner X Exercise2021-01-202021-03-31643,525$0.01 $6.4K1,931,893SEC↗
MILANO VINCENTPresident & CEO S Sale2021-01-122021-01-123,210$4.20 $13.5K208,611SEC↗
Lim Bryant DavidSVP and General Counsel S Sale2021-01-122021-01-121,711$4.21 $7.2K38,064SEC↗
Tarka Elizabeth AnnChief Medical Officer S Sale2021-01-122021-01-121,745$4.19 $7.3K18,255SEC↗
Kirby John J.Chief Financial Officer S Sale2021-01-122021-01-121,693$4.22 $7.1K33,882SEC↗
MILANO VINCENTPresident & CEO A Award deriv2021-01-082021-01-1295,000— $095,000SEC↗
Lim Bryant DavidSVP and General Counsel A Award deriv2021-01-082021-01-1251,000— $051,000SEC↗
Tarka Elizabeth AnnChief Medical Officer A Award deriv2021-01-082021-01-1251,000— $051,000SEC↗
Kirby John J.Chief Financial Officer A Award deriv2021-01-082021-01-1251,000— $051,000SEC↗
Kirby John J.Chief Financial Officer S Sale2021-01-052021-01-06862$3.90 $3.4K35,575SEC↗
MILANO VINCENTPresident & CEO S Sale2021-01-052021-01-112,740$3.91 $10.7K211,821SEC↗
Lim Bryant DavidSVP and General Counsel S Sale2021-01-052021-01-111,465$3.91 $5.7K39,775SEC↗
SOLAND DANIEL BChief Operating Officer A Award deriv2021-01-042021-01-05200,000— $0200,000SEC↗
DOUGHERTY MICHAEL RDirector A Award2021-01-042021-01-063,515$4.02 $14.1K37,645SEC↗
GERAGHTY JAMES ADirector A Award2021-01-042021-01-064,851$4.02 $19.5K104,770SEC↗
Goldberg Mark AlanDirector A Award2021-01-042021-01-063,452$4.02 $13.9K38,099SEC↗
SCHAFER CAROLDirector A Award2021-01-042021-01-063,620$4.02 $14.6K48,488SEC↗
MILANO VINCENTPresident & CEO S Sale2020-12-222020-12-2237,169$4.32 $160.6K214,561SEC↗
MILANO VINCENTPresident & CEO A Award2020-12-182020-12-22128,170— $0251,730SEC↗
Umari Abude10% Owner P Buy deriv2020-12-112020-12-15766,941— $0766,941SEC↗
Umari Abude10% Owner P Buy deriv2020-12-112020-12-151,143,428— $01,143,428SEC↗
Umari Abude10% Owner P Buy deriv2020-12-112020-12-151,533,883— $01,533,883SEC↗
Umari Abude10% Owner P Buy deriv2020-12-112020-12-15606,885— $0606,885SEC↗
Umari Abude10% Owner P Buy2020-12-112020-12-1569,941$1.82 $127.3K5,497,638SEC↗
DOUGHERTY MICHAEL RDirector A Award2020-10-012020-10-055,722$2.25 $12.9K34,130SEC↗
GERAGHTY JAMES ADirector A Award2020-10-012020-10-058,666$2.25 $19.5K99,919SEC↗
Goldberg Mark AlanDirector A Award2020-10-012020-10-056,166$2.25 $13.9K34,647SEC↗
PIEN HOWARD HDirector A Award2020-10-012020-10-055,583$2.25 $12.6K45,457SEC↗
SCHAFER CAROLDirector A Award2020-10-012020-10-056,111$2.25 $13.7K44,868SEC↗
MILANO VINCENTPresident & CEO A Award deriv2020-07-212020-07-2392,000— $092,000SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award deriv2020-07-212020-07-2350,000— $050,000SEC↗
Kirby John J.Chief Financial Officer A Award deriv2020-07-212020-07-2350,000— $050,000SEC↗
Lim Bryant DavidSVP and General Counsel A Award deriv2020-07-212020-07-2350,000— $050,000SEC↗
Tarka Elizabeth AnnChief Medical Officer A Award deriv2020-07-212020-07-2350,000— $050,000SEC↗
Pillar Partners Foundation, L.10% Owner P Buy deriv2020-07-132020-07-152,014,234— $02,014,234SEC↗
Pillar Partners Foundation, L.10% Owner P Buy deriv2020-07-132020-07-152,764,227— $02,764,227SEC↗
Pillar Partners Foundation, L.10% Owner P Buy2020-07-132020-07-15749,993$1.72 $1.29M5,427,697SEC↗
DOUGHERTY MICHAEL RDirector A Award2020-07-012020-07-027,193$1.79 $12.9K28,408SEC↗
GERAGHTY JAMES ADirector A Award2020-07-012020-07-0210,894$1.79 $19.5K91,253SEC↗
Goldberg Mark AlanDirector A Award2020-07-012020-07-027,751$1.79 $13.9K28,481SEC↗
PIEN HOWARD HDirector A Award2020-07-012020-07-027,018$1.79 $12.6K39,874SEC↗
SCHAFER CAROLDirector A Award2020-07-012020-07-027,681$1.79 $13.7K38,757SEC↗
ZEIN YOUSSEF EL10% Owner P Buy deriv2020-05-122020-09-043,039,514— $03,039,514SEC↗
Csimma CristinaDirector A Award deriv2020-05-122020-05-1911,500— $011,500SEC↗
DOUGHERTY MICHAEL RDirector A Award deriv2020-05-122020-05-1911,500— $011,500SEC↗
Goldberg Mark AlanDirector A Award deriv2020-05-122020-05-1911,500— $011,500SEC↗
GOWEN MAXINEDirector A Award deriv2020-05-122020-05-1911,500— $011,500SEC↗
PIEN HOWARD HDirector A Award deriv2020-05-122020-05-1911,500— $011,500SEC↗
SCHAFER CAROLDirector A Award deriv2020-05-122020-05-1911,500— $011,500SEC↗
GERAGHTY JAMES ADirector A Award deriv2020-05-122020-05-1914,500— $014,500SEC↗
Pillar Partners Foundation, L.10% Owner J Other2020-04-172020-09-0446,304— $05,427,697SEC↗
Pillar Partners Foundation, L.10% Owner J Other2020-04-172020-09-04103,891— $01,288,368SEC↗
Pillar Partners Foundation, L.10% Owner P Buy2020-04-072020-04-093,039,514$1.52 $4.62M6,260,832SEC↗
DOUGHERTY MICHAEL RDirector A Award2020-04-012020-04-0310,059$1.28 $12.9K21,215SEC↗
GERAGHTY JAMES ADirector A Award2020-04-012020-04-0314,926$1.28 $19.1K80,359SEC↗
Goldberg Mark AlanDirector A Award2020-04-012020-04-0310,730$1.28 $13.7K20,730SEC↗
PIEN HOWARD HDirector A Award2020-04-012020-04-039,666$1.28 $12.4K32,856SEC↗
SCHAFER CAROLDirector A Award2020-04-012020-04-0310,633$1.28 $13.6K31,076SEC↗
Pillar Pharmaceuticals III, L.10% Owner S Sale2020-01-292020-02-2617,250$1.76 $30.4K3,254,442SEC↗
Pillar Pharmaceuticals III, L.10% Owner S Sale2020-01-282020-02-2612,532$1.76 $22.1K3,271,692SEC↗
Pillar Pharmaceuticals III, L.10% Owner S Sale2020-01-272020-02-2615,000$1.77 $26.6K3,284,224SEC↗
MILANO VINCENTPresident & CEO A Award deriv2020-01-102020-01-1492,000— $092,000SEC↗
Kirby John J.Chief Financial Officer A Award deriv2020-01-102020-01-1450,000— $050,000SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award deriv2020-01-102020-01-1450,000— $050,000SEC↗
Lim Bryant DavidSVP and General Counsel A Award deriv2020-01-102020-01-1450,000— $050,000SEC↗
Tarka Elizabeth AnnChief Medical Officer A Award deriv2020-01-102020-01-1450,000— $050,000SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer A Award deriv2020-01-102020-01-1450,000— $050,000SEC↗
MILANO VINCENTPresident & CEO A Award2020-01-102020-01-1437,000— $0123,560SEC↗
Kirby John J.Chief Financial Officer A Award2020-01-102020-01-1420,000— $036,437SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award2020-01-102020-01-1420,000— $036,485SEC↗
Lim Bryant DavidSVP and General Counsel A Award2020-01-102020-01-1420,000— $041,240SEC↗
Tarka Elizabeth AnnChief Medical Officer A Award2020-01-102020-01-1420,000— $020,000SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer A Award2020-01-102020-01-1420,000— $036,358SEC↗
Lim Bryant DavidSVP and General Counsel S Sale2020-01-072020-01-101,603$1.78 $2.9K21,240SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy S Sale2020-01-072020-01-101,615$1.78 $2.9K16,485SEC↗
Kirby John J.Chief Financial Officer S Sale2020-01-072020-01-10911$1.78 $1.6K16,437SEC↗
MILANO VINCENTPresident & CEO S Sale2020-01-072020-01-103,006$1.78 $5.4K86,560SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer S Sale2020-01-072020-01-101,742$1.78 $3.1K16,358SEC↗
MILANO VINCENTPresident & CEO S Sale2020-01-072020-01-143,006$1.78 $5.4K86,560SEC↗
Kirby John J.Chief Financial Officer S Sale2020-01-072020-01-14911$1.78 $1.6K16,437SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy S Sale2020-01-072020-01-141,615$1.78 $2.9K16,485SEC↗
Lim Bryant DavidSVP and General Counsel S Sale2020-01-072020-01-141,603$1.78 $2.9K21,240SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer S Sale2020-01-072020-01-141,742$1.78 $3.1K16,358SEC↗
PIEN HOWARD HDirector A Award2020-01-022020-01-066,790$1.85 $12.6K23,190SEC↗
DOUGHERTY MICHAEL RDirector A Award2020-01-022020-01-067,037$1.85 $13.0K11,156SEC↗
Pillar Pharmaceuticals 6, L.P.10% Owner S Sale2019-11-082019-11-089,000$2.44 $22.0K3,299,224SEC↗
Pillar Pharmaceuticals 6, L.P.10% Owner S Sale2019-11-072019-11-0810,000$2.45 $24.5K3,308,224SEC↗
Pillar Pharmaceuticals 6, L.P.10% Owner S Sale2019-11-062019-11-08100,000$2.50 $250.0K3,318,224SEC↗
SCHAFER CAROLDirector A Award2019-10-012019-10-025,098$2.67 $13.6K20,443SEC↗
DOUGHERTY MICHAEL RDirector A Award2019-10-012019-10-024,119$2.67 $11.0K4,119SEC↗
PIEN HOWARD HDirector A Award2019-10-012019-10-024,610$2.67 $12.3K16,400SEC↗
Tarka Elizabeth AnnChief Medical Officer A Award deriv2019-07-222019-07-23130,000— $0130,000SEC↗
MILANO VINCENTPresident & CEO A Award deriv2019-07-092019-07-1184,500— $084,500SEC↗
Lim Bryant DavidSVP and General Counsel A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
Horobin JoannaChief Medical Officer A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
Kirby John J.VP of Finance A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
SCHAFER CAROLDirector A Award2019-07-012019-07-025,179$2.61 $13.5K15,345SEC↗
PIEN HOWARD HDirector A Award2019-07-012019-07-024,469$2.61 $11.7K11,790SEC↗
BAKER JULIAN10% Owner A Award2019-07-012019-07-032,964$2.61 $7.7K4,290,995SEC↗
BAKER JULIAN10% Owner A Award2019-07-012019-07-032,964$2.61 $7.7K350,721SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-07880— $0880SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-071,660— $01,660SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-076,256— $06,256SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-076,256— $06,256SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-071,660— $01,660SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-07880— $0880SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-076,009— $00SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-0711,337— $00SEC↗
BAKER FELIX10% Owner J Other deriv2019-06-062019-06-0742,724— $00SEC↗
BAKER FELIX10% Owner J Other2019-06-062019-06-07178,967— $0347,757SEC↗
BAKER FELIX10% Owner J Other2019-06-062019-06-0721,929— $021,929SEC↗
BAKER FELIX10% Owner J Other2019-06-062019-06-0759,267— $00SEC↗
BAKER FELIX10% Owner J Other2019-06-062019-06-0721,929— $021,929SEC↗
Csimma CristinaDirector A Award deriv2019-06-042019-06-0611,500— $011,500SEC↗
DOUGHERTY MICHAEL RDirector A Award deriv2019-06-042019-06-0611,500— $011,500SEC↗
Goldberg Mark AlanDirector A Award deriv2019-06-042019-06-0611,500— $011,500SEC↗
GOWEN MAXINEDirector A Award deriv2019-06-042019-06-0611,500— $011,500SEC↗
PIEN HOWARD HDirector A Award deriv2019-06-042019-06-0611,500— $011,500SEC↗
SCHAFER CAROLDirector A Award deriv2019-06-042019-06-0611,500— $011,500SEC↗
GERAGHTY JAMES ADirector A Award deriv2019-06-042019-06-0614,500— $014,500SEC↗
Csimma CristinaDirector A Award deriv2019-04-082019-04-1023,000— $023,000SEC↗
DOUGHERTY MICHAEL RDirector A Award deriv2019-04-082019-04-1023,000— $023,000SEC↗
SCHAFER CAROLDirector A Award2019-04-012019-04-025,166$2.59 $13.4K10,166SEC↗
PIEN HOWARD HDirector A Award2019-04-012019-04-024,392$2.59 $11.4K7,321SEC↗
667, L.P.Director, 10% Owner A Award2019-04-012019-04-034,161$2.59 $10.8K89,233SEC↗
667, L.P.Director, 10% Owner A Award2019-04-012019-04-034,161$2.59 $10.8K4,288,031SEC↗
667, L.P.Director, 10% Owner A Award2019-04-012019-04-034,161$2.59 $10.8K526,724SEC↗
MILANO VINCENTPresident & CEO A Award deriv2019-01-032019-01-0784,500— $084,500SEC↗
Lim Bryant DavidSVP and General Counsel A Award deriv2019-01-032019-01-0745,500— $045,500SEC↗
Kirby John J.VP of Finance A Award deriv2019-01-032019-01-0725,600— $025,600SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award deriv2019-01-032019-01-0745,500— $045,500SEC↗
Horobin JoannaChief Medical Officer A Award deriv2019-01-032019-01-0745,500— $045,500SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer A Award deriv2019-01-032019-01-0745,500— $045,500SEC↗
MILANO VINCENTPresident & CEO A Award2019-01-032019-01-0733,750— $089,566SEC↗
Lim Bryant DavidSVP and General Counsel A Award2019-01-032019-01-0718,100— $022,843SEC↗
Kirby John J.VP of Finance A Award2019-01-032019-01-0710,250— $012,509SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award2019-01-032019-01-0718,100— $018,100SEC↗
Horobin JoannaChief Medical Officer A Award2019-01-032019-01-0718,100— $020,144SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer A Award2019-01-032019-01-0718,100— $018,100SEC↗
PIEN HOWARD HDirector A Award2019-01-022019-01-032,929$3.52 $10.3K2,929SEC↗
14159, L.P.Director, 10% Owner A Award2019-01-022019-01-043,658$3.52 $12.9K85,072SEC↗
14159, L.P.Director, 10% Owner A Award2019-01-022019-01-043,658$3.52 $12.9K4,283,870SEC↗
14159, L.P.Director, 10% Owner A Award2019-01-022019-01-043,658$3.52 $12.9K522,563SEC↗
MILANO VINCENTPresident & CEO P Buy2018-12-242018-12-2615,000$2.93 $44.0K55,816SEC↗
Lim Bryant DavidSVP and General Counsel P Buy2018-12-212018-12-264,000$3.05 $12.2K4,743SEC↗
Horobin JoannaChief Medical Officer P Buy2018-12-202018-12-20300$3.45 $1.0K2,044SEC↗
SCHAFER CAROLDirector P Buy2018-12-192018-12-205,000$3.33 $16.6K5,000SEC↗
Goldberg Mark AlanDirector P Buy2018-12-192018-12-2010,000$3.19 $31.9K10,000SEC↗
SCHAFER CAROLDirector A Award deriv2018-12-182018-12-2023,000— $023,000SEC↗
BAKER BROS. ADVISORS LPDirector, 10% Owner A Award2018-10-012018-10-032,340$8.71 $20.4K81,414SEC↗
BAKER BROS. ADVISORS LPDirector, 10% Owner A Award2018-10-012018-10-032,340$8.71 $20.4K4,280,212SEC↗
BAKER BROS. ADVISORS LPDirector, 10% Owner A Award2018-10-012018-10-032,340$8.71 $20.4K518,905SEC↗
PIEN HOWARD HDirector A Award deriv2018-09-182018-09-2023,000— $023,000SEC↗
Lim Bryant DavidSVP and General Counsel A Award deriv2018-09-102018-09-13130,000— $0130,000SEC↗
YINGLING JONATHAN MICHAELChief Scientific Officer A Award deriv2018-08-132018-08-1532,500— $032,500SEC↗
Horobin JoannaChief Medical Officer A Award deriv2018-08-132018-08-1532,500— $032,500SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award deriv2018-08-132018-08-1532,500— $032,500SEC↗
Arcudi III Louis JChief Financial Officer A Award deriv2018-08-132018-08-1532,500— $032,500SEC↗
MILANO VINCENTPresident & CEO A Award deriv2018-08-132018-08-1565,000— $065,000SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-092018-08-1715,000$6.25 $93.8K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-092018-08-1725,000$6.29 $157.3K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-092018-08-1715,000$6.35 $95.3K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-082018-08-1720,000$5.98 $119.6K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-082018-08-1750,000$5.88 $294.0K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-082018-08-178,107$5.89 $47.8K0SEC↗
GERAGHTY JAMES ADirector P Buy2018-08-072018-08-0810,000$5.58 $55.8K65,433SEC↗
MILANO VINCENTPresident & CEO P Buy2018-08-072018-08-0810,000$5.51 $55.1K40,816SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-072018-08-1791,893$5.55 $510.0K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-08-072018-08-1775,000$5.62 $421.5K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-07-202018-07-24492,567$0.86 $423.6K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-07-192018-07-24556,000$0.88 $489.3K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2018-07-182018-07-241,725,000$0.85 $1.47M0SEC↗
Pillar Invest Corp10% Owner S Sale2018-07-172018-07-19874,505$0.99 $865.8K0SEC↗
Pillar Invest Corp10% Owner S Sale2018-07-162018-07-19735,771$1.01 $743.1K0SEC↗
Pillar Invest Corp10% Owner S Sale2018-07-132018-07-19250,500$1.05 $263.0K0SEC↗
GERAGHTY JAMES ADirector A Award2018-07-022018-07-058,096$1.32 $10.7K443,465SEC↗
Baker Brothers Life Sciences LDirector, 10% Owner A Award2018-07-022018-07-0516,383$1.32 $21.6K34,222,983SEC↗
Baker Brothers Life Sciences LDirector, 10% Owner A Award2018-07-022018-07-0516,383$1.32 $21.6K632,599SEC↗
Baker Brothers Life Sciences LDirector, 10% Owner A Award2018-07-022018-07-0516,383$1.32 $21.6K4,132,528SEC↗
Baker Bros. Advisors (GP) LLCDirector, 10% Owner A Award deriv2018-06-202018-06-21100,000— $0100,000SEC↗
REARDON WILLIAM SDirector A Award deriv2018-06-202018-06-2250,000$1.53 $76.5K50,000SEC↗
GOWEN MAXINEDirector A Award deriv2018-06-202018-06-2250,000$1.53 $76.5K50,000SEC↗
Goldberg Mark AlanDirector A Award deriv2018-06-202018-06-2250,000$1.53 $76.5K50,000SEC↗
GERAGHTY JAMES ADirector A Award deriv2018-06-202018-06-2263,000$1.53 $96.4K63,000SEC↗
Pillar Invest Corp10% Owner X Exercise deriv2018-04-252018-04-271,200,000— $00SEC↗
Pillar Invest Corp10% Owner X Exercise2018-04-252018-04-271,200,000— $00SEC↗
667, L.P.Director A Award2018-04-022018-04-0413,349$1.62 $21.6K4,116,145SEC↗
667, L.P.Director A Award2018-04-022018-04-0413,349$1.62 $21.6K34,206,600SEC↗
667, L.P.Director A Award2018-04-022018-04-0413,349$1.62 $21.6K616,216SEC↗
BAKER FELIXDirector, 10% Owner M Exercise deriv2018-03-152018-03-1517,626,445— $00SEC↗
BAKER FELIXDirector, 10% Owner M Exercise deriv2018-03-152018-03-152,250,846— $00SEC↗
BAKER FELIXDirector, 10% Owner M Exercise deriv2018-03-152018-03-15439,036— $00SEC↗
BAKER FELIXDirector, 10% Owner M Exercise2018-03-152018-03-15439,036$0.47 $206.3K602,867SEC↗
BAKER FELIXDirector, 10% Owner M Exercise2018-03-152018-03-1517,626,445$0.47 $8.28M34,193,251SEC↗
BAKER FELIXDirector, 10% Owner M Exercise2018-03-152018-03-152,250,846$0.47 $1.06M4,102,796SEC↗
Pillar Pharmaceuticals III, L.10% Owner S Sale2018-01-172018-01-19200,000$2.40 $480.0K0SEC↗
Casey Mark JSenior VP & General Counsel A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
Arcudi III Louis JChief Financial Officer A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
Fletcher Robert C.Sr. VP, Bus. Dev. & Strategy A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
Horobin JoannaChief Medical Officer A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
YINGLING JONATHAN MICHAELSVP, Early Development A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
MILANO VINCENTPresident & CEO A Award deriv2018-01-032018-01-05600,000$2.24 $1.34M600,000SEC↗
667, L.P.Director A Award2018-01-022018-01-049,333$2.21 $20.6K16,566,806SEC↗
667, L.P.Director A Award2018-01-022018-01-049,333$2.21 $20.6K163,831SEC↗
667, L.P.Director A Award2018-01-022018-01-049,333$2.21 $20.6K1,851,950SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2017-12-152017-12-1533,830$1.91 $64.6K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner X Exercise deriv2017-12-142017-12-15700,000— $00SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2017-12-142017-12-15166,170$2.01 $334.0K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner X Exercise2017-12-142017-12-15700,000— $00SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2017-12-142017-12-15700,000$2.00 $1.40M0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2017-12-142017-12-15300,000$2.00 $600.0K0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2017-12-132017-12-15600,000$1.93 $1.16M0SEC↗
Pillar Pharmaceuticals II, L.P10% Owner S Sale2017-12-132017-12-15500,000$1.92 $960.0K0SEC↗
Baker Brothers Life Sciences LDirector P Buy2017-10-262017-10-307,204,652$1.50 $10.81M16,557,473SEC↗
Baker Brothers Life Sciences LDirector P Buy2017-10-262017-10-30795,348$1.50 $1.19M1,842,617SEC↗
Pillar Pharmaceuticals II, L.PDirector, 10% Owner X Exercise deriv2017-10-162017-10-176,842,844— $00SEC↗
Pillar Pharmaceuticals II, L.PDirector, 10% Owner X Exercise2017-10-162017-10-176,842,844— $00SEC↗